Democratic Republic of the Congo

Last Updated 24 January 2022.

4 Vaccines Approved for Use in Democratic Republic of the Congo

• Moderna
  Spikevax

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 85 countries

  45 trials in 19 countries

  Approval Source: actualite.cd

  RNA

• Pfizer/BioNTech
  Comirnaty

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 136 countries

  58 trials in 24 countries

  Approval Source: actualite.cd

  RNA

• Janssen (Johnson & Johnson)
  Ad26.COV2.S

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 106 countries

  18 trials in 18 countries

  Approval Source: actualite.cd

  Non Replicating Viral Vector

• Oxford/AstraZeneca
  Vaxzevria

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 137 countries

  56 trials in 30 countries

  Approval Source: aa.com.tr

  Non Replicating Viral Vector

0 Vaccines in Clinical Trials in Democratic Republic of the Congo